Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaorusanjie Capsules
- Development stage
- Unknown
- Lead developer
- 山东步长神州制药
- Administration
- Oral
01
Overview
Xiaorusanjie Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is primarily indicated for the treatment of breast diseases, specifically hyperplasia of mammary glands (mastopathy) and breast nodules. The formulation is designed to regulate Qi, activate blood circulation, and soften hardness to dissipate nodules, which are core therapeutic principles in TCM for managing benign breast masses and associated pain. It is an approved pharmaceutical product in China and is widely utilized in gynecological clinical practice.
- Brand names
- Xiaorusanjie Capsules
- Other names
- Xiaorusanjie Jiaonang
Beyond the preview
Go deeper on Xiaorusanjie Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaorusanjie Capsules.